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We recently reported the use of a gene-trapping approach to isolate cell clones
in which a reporter gene had integrated into genes modulated by T-cell activa-
tion. We have now tested a panel of clones from that report and identified the
one that responds to a variety of G-protein coupled receptors (GPCR). The β-
lactamase tagged EGR-3 Jurkat cell was used to dissect specific GPCR signaling
in vivo. Three GPCRs were studied, including the chemokine receptor CXCR4 (Gi-
coupled) that was endogenously expressed, the platelet activation factor (PAF) re-
ceptor (Gq-coupled), and β2 adrenergic receptor (Gs-coupled) that was both stably
transfected. Agonists for each receptor activated transcription of the β-lactamase
tagged EGR-3 gene. Induction of EGR-3 through CXCR4 was blocked by pertussis
toxin and PD58059, a specific inhibitor of MEK (MAPK/ERK kinase). Neither of
these inhibitors blocked isoproterenol or PAF-mediated activation of EGR-3. Con-
versely, β2- and PAF-mediated EGR-3 activation was blocked by the p38, specific
inhibitor SB580. In addition, both β2- and PAF-mediated EGR-3 activation could
be synergistically activated by CXCR4 activation. This combined result indicates
that EGR-3 can be activated through distinct signal transduction pathways by dif-
ferent GPCRs and that signals can be integrated and amplified to efficiently tune
the level of activation.
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Introduction
A variety of extracellular stimuli can target trans-
membrane molecules to activate intracellular signal
transduction. These signals are then transduced
through the cell by signaling cascades to regulate cel-
lular processes such as differentiation, proliferation
and apoptosis (1 , 2 ). One specific intracellular event
is the activation of mitogen-activated protein kinases
(MAPKs; ref. 3 ) which are divided into three major
classes: MAPK/ERK, JNK/SAPK, and p38 MAPK
(4 ). These three classes of MAPKs are likely to work
independently and synergistically to regulate cellular
processes. MAPK/ERK is commonly stimulated by
growth factors and cytokines, and phosphorylates var-
ious target proteins to transmit signals and regulate
cellular events. JNK/SAPK is activated by stresses
such as osmotic shock and ultraviolet radiation, and
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leads to phosphorylation of C-Jun, a component of
AP-1 (5 ), which subsequently activates transcription.
The third class including p38 MAPK was identified as
the target of lipopolysaccharide (LPS) treatment (6 ),
but targets of p38 MAPK are currently unknown.
Recently, a number of receptors that couple to het-
erotrimeric G-proteins (guanine nucleotide-binding
regulatory proteins) have been shown to stimulate
MAPKs (7 , 8 ) through differential coupling of their
various G-protein subunits to specific MAPKs (9 ). It
is therefore possible that MAPK activation by GPCRs
(G-protein coupled receptors) can be proceed by mul-
tiple signal transduction pathways, leading to the ac-
tivation of specific downstream genes and the desired
biological response. Since the identification of genes
that are regulated by specific stimuli is of fundamental
importance in understanding cellular processes, much
effort has been made to develop an effective approach
to identify these genes and their mechanism of acti-
vation. In MAPK signaling, cross talk between path-
ways occurs in many cases, making the study of spe-
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cific functions of certain genes a difficult task.
In our previous paper (10 ), we described a func-
tional genomic assay to isolate cell clones and iden-
tify genes responsive to a specific signal transduction
pathway. Here we report the use of one clone (JTIC-
3) generated with this approach to study specific gene
regulation activated by GPCR signaling. We show
how these three GPCRs, which are coupled to one of
the three major G-protein α-subunits Gq, Gs, or Gi,
induce activation of a common transcription factor
through MAPK signaling pathways.
Results and Discussion
GPCRs modulate transcription of β-
lactamase tagged EGR-3
Gene trapping is a powerful approach for the study of
gene regulation and function. In our previous report,
we combined flow cytometry and gene trapping in live
cells to isolate cell clones induced by a specific stimuli
(T-cell activation). The signal transduction of the cell
clones isolated by this method was shown to be de-
pendent on various second messenger cascades includ-
ing Ca2+ and PKC (protein kinase C). Specifically, all
clones were isolated for their activation by PHA (phy-
tohemagglutinin), but individual clones showed selec-
tive activation by PMA (phorbol myristate acetate),
thapsigargin, or PMA+thapsigargin. A panel of these
clones with robust signal, low background and varied
dependence for stimuli was selected to test for activa-
tion by selected GPCRs. One specific clone (JTIC-3)
responded to a variety of GPCRs at different levels.
This clone, JTIC-3, has the β-lactamase reporter in-
tegrated into and functionally tagged on the EGR-3
gene (11 , 12 ). EGR-3 and related proteins are a class
of Zinc finger transcription factors that recognize the
same consensus DNA sequence. The transcription ac-
tivity of EGR-3 is highly concentrated in the CNS
(central nervous system; ref. 13 ). It was previously
showed that EGR-3 was activated by T-cell receptor
activation. In addition, several reports from experi-
ments in mice have shown that mouse analogs egr-1,
egr-2, egr-3, and egr-4 signal transduction pathways
are connected with some GPCRs (14 , 15 ).
Recently, CXCR4 was identified as a native re-
ceptor for chemokine peptide stromal cell-derived fac-
tor 1 (SDF-1; ref. 16 , 17 ). This receptor is ex-
pressed endogenously in Jurkat cells and has re-
cently been shown to function as a co-receptor for
lymphocyte-tropic HIV-1 required for cellular infec-
tion (18 ). When human SDF-1 was tested on Jurkat
cells or on a CHO (Chinese hamster ovary) cell clone
stably expressing CXCR4, a transient rise of cytoso-
lic free Ca2+ was observed. When we tested the ac-
tivation of JTIC-3 by different GPCRs, CXCR4 was
one of the receptors to activate EGR-3 when stimu-
lated with SDFα peptide, an active fragment of SDF-1
(Figure 1A). The activation of the EGR-3 gene was in
a dose-dependent manner with an EC50 of ∼10 nM
(Figure 1B). This result indicated that besides T-cell
stimulation shown in prior reports, SDF-1 could also
induce transcription of EGR-3. Interestingly, SDF-1
has been shown to inhibit infection by HIV-1 and this
inhibition is believed to occur through SDF-1 com-
petition with viruses for binding to CXCR4 (16 , 17 ).
Because of this, the JTIC-3 cell line may be useful
to identify inhibitors or analogs of SDF-1 that can
inhibit HIV-1 infection.
For assessing the dependence of EGR-3 induction
by GPCRs that are not natively expressed in Jurkat
cells, we generated stable transfect cell lines derived
from JTIC-3 expressing an exogenous receptor. JTIC-
3 was transfected with the PAFR (platelet activation
factor receptor) and β2R so that one member of each
of the three classes of GPCRs (Gi, Gs, and Gq) was
represented. Individual cell clones responding to PAF
and β2 receptor agonist isoproterenol were isolated us-
ing flow cytometry followed by testing for activation
by their respective agonist. The results showed that
β2 receptor activated the β-lactamase tagged EGR-
3 less than CXCR4 or PAFR (Figure 1C). To con-
firm the specific involvement of β2 receptor, we used
two potent β2 receptor antagonists, ICI-158 and pro-
prenolol, to perform inhibition assays. Both antag-
onists totally blocked the isoproterenol mediated β-
lactamase expression (data not shown). This result
indicated that the isoproterenol induced activation of
EGR-3 is specifically mediated by β2 receptor. Taken
together, the above results demonstrate that all three
classes of GPCRs (Gi, Gq, and Gs) can activate the
transcription of EGR-3.
To investigate which receptor-linked effector might
be responsible for EGR-3 activation, we also exam-
ined the effects of various inhibitors on the GPCR-
linked activation. PTX totally blocked the EGR-3
activation induced by SDF-1 (Figure 2), but had no
effect on the EGR-3 activation induced by PAF or
isoproterenol. PTX (pertussis toxin) is known to in-
duce the ADP-ribosylation of Gi/Go subunits of the
G-protein complex, thus preventing the dissociation
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Fig. 1 β-lactamase reporter gene activation by GPCRs
expressed endogenously or exogenously in genomic clone
JTIC-3. T cell endogenous CXC-4 receptor, or stably
transfected PAF receptor, β2 receptor in JTIC-3 was stim-
ulated with (solid bar) or without (open bar) their re-
spective agonist, with 0.1 µg/mL SDFα (A), 1 µM PAF
or 10 µM isoproterenol (C). All the cells were plated in
96-well plates at 100,000 cells per well. After 6 h incu-
bation with agonist at 37˚C, the cells were loaded with
1 µM CCF2/AM at room temperature for 1 h and then
read on a Cytofluor 4000 fluorescence plate reader, with
excitation 390 nm, emission 460 (blue) and 530 (green).
Ratio changes of 460 vs 530 were used to determine β-
lactamase activity. Bars represent means ± S.D. for trip-
licate samples. EC50 value for SDFα dose response (B)
was determined using PrismTM software.
Fig. 2 Effect of PTX on different GPCR mediated sig-
nal transduction. Individual cell line was pre-incubated
in the presence or absence of 100 ng/mL PTX overnight.
The cells were then stimulated with their respective ago-
nist (1 µM PAF, 10 µM isoproterenol, 0.1 µg/mL SDFα).
Cell stimulation and CCF-2 dye loading condition are the
same as described in Figure 1.
of Gαi/o and β/γ subunits (1 ). This result indicated
that as expected, the PTX-sensitive Gαi/o was in-
volved in the EGR-3 activation mediated by SDF-1.
It has been reported that Gi and Gs coupled re-
ceptors activate MAPK pathway through Gβγ . To
confirm the role of Gα in MAPK signaling, we trans-
fected the constitutively activated Gαq, Gαs, and Gαi
mutants into our reporter cell line transiently. The
Gαq mutant activated EGR-3 reporter gene expres-
sion while Gαs and Gαi mutants failed to show any
effect (data not shown). This result, together with
the result from PTX assay, suggested that Gβγ sub-
units may be responsible for the Gs and Gi coupled
receptor activation of EGR-3.
GPCRs activate EGR-3 expression
through various MAPK pathways
MAPKs are activated in response to diverse extra-
cellular signals. They then phosphorylate a vari-
ety of intracellular substrates including other kinases
and transcription factors, which in turn modulate the
expression of target genes implicated in cell growth
(4 , 19 ). It has recently become apparent that GPCRs
can induce intracellular signal transduction through
MAPK pathways (9 , 20 ). It is therefore quite log-
ical to investigate the involvement of MAPKs in
EGR-3 activation. For this analysis we used the
JTIC-3 clone and its subclones that had been trans-
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fected with the PAF or β2 receptor. In Figure 3,
we show the inhibition profiles of different GPCR-
mediated transcription activity by different MAPK
inhibitors. Compound PD58059, which is specific for
MEK (MAPK/ERK kinase), blocked SDFα-induced
β-lactamase induction (Figure 3A), but failed to block
β2- and PAF-receptor induced β-lactamase induction.
Conversely, the p38 specific inhibitor SB580 blocked
β2- and PAF-receptor mediated activation of EGR-3
(Figure 3B and 3C), but failed to act on SDF induced
activation. These results indicate that all the three
GPCRs activate EGR-3 transcription through MAPK
pathways, but the CXCR4 pathway is distinct from
the pathway used by PAF and β2 receptors. When
some GPCRs were found to activate p38 MAPK, one
question that remained to be answered was whether
all GPCRs elicit their signals to p38 (21 ). Our results
indicate that GPCR signals could go through diver-
sified MAPK pathways, but may result in regulating
the same cellular target. The significance of the diver-
sity of MAPK activation by different GPCRs should
be further investigated.
Synergistic effects in MAPK cascades
Even though different MAPK subgroups are acti-
vated through distinct, sometime partially overlap-
ping cascades, there are cases when MAPKs can re-
spond synergistically to different upstream signals,
resulting in the integration of effects from distinct
stimuli (22 , 23 ). To test possible synergistic effects
among GPCRs on MAPK signaling pathways, we
co-stimulated the JTIC-3/PAFR, JTIC-3/β2R clones
with sub-threshold concentration of SDFα and var-
ious concentration of PAF or isoproterenol respec-
tively. In the presence of minimum amounts of SDFα,
both isoproterenol and PAF treatment resulted in a
significant synergistic activation of EGR-3 (Figure 4A
and 4B). Treatment of JTIC-3/β2R clone with β2 re-
ceptor antagonist ICI-158 inhibited the synergistic ef-
fect (Figure 5A). On the other hand, treatment of
JTIC-3/PAFR clone with MAPK inhibitor PD98059
(specific to CXCR4-induced MAPK signaling) totally
abolished the synergistic effect of SDFα and PAF, and
the effects were also partially blocked by MAPK in-
hibitor SB203580 (specific to PAFR-induced MAPK
signaling; Figure 5B). This experiment clearly indi-
cated that the synergy of different GPCRs in cellular
signaling activities and the activation of EGR-3 were
transmitted from integration of multiple MAPK path-
ways. Synergistic activation of MAPKs by different
Fig. 3 Inhibition of GPCR-MAPK mediated signal
transduction. Individual cell line was pre-incubated
in the presence of different MAPK inhibitor including
SB202190, SB202358, PD98059 or negative inhibitor con-
trol SB202474 at 37˚C overnight (see Materials and Meth-
ods). The cells were then stimulated with their respec-
tive agonist (1 µM PAF, 10 µM isoproterenol, 0.1 µg/mL
SDF). Cell stimulation and CCF-2 dye loading condition
are the same as described in Figure 1.
stimuli has been reported for various physiological
functions such as regulating intracellular signaling
and correlating the cell growth (23 ). The significance
of synergistic effects applied by multiple GPCRs has
not been clearly studied.
Using our gene-trapping technique, we have estab-
lished that EGR-3 is a target of MAPK activation.
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Fig. 4 Synergistic effect of GPCR-MAPK mediated sig-
nal transduction. A. Stimulation of cells with different
concentration of PAF in the presence or absence of mini-
mum amount of SDF peptide. B. Stimulation of cells with
different concentration of isoproterenol in the presence or
absence of minimum amount of SDF peptide. Cell stim-
ulation and CCF-2 dye loading condition are the same as
described in Figure 1.
The illustration demonstrates the relationship be-
tween different GPCRs/MAPKs to enhance our cur-
rent understanding of how cells are able to respond
coordinately to diverse extra-cellular signals. Before
these findings, very few downstream targets for p38
MAPK had been identified. One of the p38 MAPK
isoforms, p38b, which has 74% sequence homology
to p38, displays activity toward activating transcrip-
tion factor 2 (ATF2; ref. 24 ), while p38 shows lit-
tle effect on this transcription factor. Whether the
EGR-3 activation was due to p38 or p38b remains
to be seen. The p38 protein is found to be a major
tyrosine-phosphorylated protein following LPS treat-
ment (25 ). It has been suggested that the p38 MAPK
pathway may be involved in the inhibition of cell
growth and the promotion of cell death (26 ). Involve-
ment of GPCRs in the p38 regulation may provide a
new insight into the function of both p38 and GPCRs.
A
B
Fig. 5 A. β2 receptor specific response and synergistic
effect of β2R and CXCR4 can be blocked by β2 recep-
tor antagonist ICI-158. The cells were pre-incubated with
ICI-158 for 1 h before agonist stimulation. B. Inhibition of
synergistic effect of PAFR and CXCR4 by specific MAPK
inhibitor PD98059. Cell stimulation and CCF-2 dye load-
ing condition are the same as described in Figure 1.
Materials and Methods
Materials
SDF-1α was from R&D Systems (Minneapolis,
USA). Isoproterenol, PAF, MAP Kinase Inhibitor
Set, Phorbol-12-myristate-13-acetate were from Cal-
biochem (San Diego, USA). PTX and β2 receptor
antagonist ICI-158 were from RBI (Natick, USA).
Phytohemagglutinin-M, RPMI 1640 media, heat in-
activated FBS, were from Gibco/BRL (Gaithersburg,
USA). Human β2 receptor expression plasmid (pβ2r)
was from Dr. M. Simon. Human PAFR expression
plasmid (pPAFR) was provided by Dr. R. Yeh.
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Genomic clone JTIC-3
The method to generate clone JTIC-3 in which en-
dogenous EGR-3 was functionally tagged with a β-
lactamase reporter is as described by Whitney et al.
(10 ). Briefly, a cell library was created using a gene-
trapping approach to have exogenous gene (promoter-
less β-lactamase reporter gene) spliced into an en-
dogenous gene and generate a fusion RNA when the
gene trap vector has properly inserted into a host in-
tron. The plasmid vector GAS-1 was introduced into
Jurkat cells by electroporation and subsequent an-
tibiotic selection. The entire Jurkat cell pool, with
at least one million independent cell clones, was then
treated with PHA. Flow cytometry was used to isolate
cell clones in which β-lactamase had inserted into a
PHA inducible gene. Individual cell clones were then
expanded and characterized, and reporter genes were
identified.
Cell culture, transfection, and clone se-
lection
Jurkat cells were maintained in RPMI medium sup-
plemented with 10% fetal bovine serum. JTIC-3 cells
were transfected with pPAFr and pβ2r via electropo-
ration. The transfected cells were then transferred
into normal culture medium and two days later, re-
placed with a medium containing 150 µg/mL zeocin.
After about a two-week selection, a total of 5-10×106
cells were stimulated with 10 µM isoproterenol or
1 µM PAF at 37˚C for 6 h and were then loaded
with 1 µM CCF2/AM at room temperature for 1 h.
Flow cytometry was conducted using a Becton Dick-
inson FACS VantageTM with an argon laser produc-
ing 351-364 nm multi-line UV excitation. Fluores-
cence emission was detected via 460/50 (blue) and
535/40 (green) emission filters. Individual blue cells
were identified and single cells were dispensed into 96-
well micro-titer plates using CloneCyt on the FACS
VantageTM. Clones were subsequently screened, se-
lected, and expanded.
β-lactamase reporter gene assay
Cells with the β-lactamase reporter gene and endoge-
nous or exogenous receptor were plated into 96-well
plates at 100,000 cells per well. CXCR4 receptor was
stimulated with 0.5 µg/mL SDFα; PAF receptor was
stimulated with 1 µM PAF; β2 receptor was stim-
ulated with 1 µM isoproteronol. Each receptor was
stimulated at 37˚C for 6 h. The cells were loaded for
1 h with 1 µM CCF-2/AM and were read on a
Cytofluor plate reader. β-lactamase enzyme levels
were determined by comparing the fluorescence emis-
sion ratio changes of 460 nm vs 530 nm for unstimu-
lated and stimulated cells.
Inhibition of β-lactamase reporter gene
expression by MAPK inhibitors
Cells were pre-incubated in the presence or absence of
10 µM SB202190, 20 µM SB203580, 10 µM SB202474
or 10 µM PD58019 in culture medium overnight, and
were then spun down and re-suspended in serum-free
medium containing the same amount of inhibitor. Re-
porter gene assay for stimulated or unstimulated cells
is the same as described above.
Effects of PTX
Cells were pre-incubated in the presence or absence
of 100 µg/mL PTX overnight, and then were spun
down by centrifugation and were re-suspended in as-
say medium with or without PTX. Reporter gene as-
say for stimulated or unstimulated cells is the same
as described above.
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